Corrigendum to “Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK -positive advanced non-small cell lung cancer” [Lung Cancer 195 (2024) 107919]
Titel:
Corrigendum to “Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK -positive advanced non-small cell lung cancer” [Lung Cancer 195 (2024) 107919]
Auteur:
Bauman, Jessica R. Liu, Geoffrey Preeshagul, Isabel Liu, Stephen V. Melosky, Barbara Abrahami, Devin Li, Benjamin Thomaidou, Despina Duncan, Kirsten Krulewicz, Stan Rupp, Martin Lin, Jessica J.